Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis: an immune system activation disease.

S Macor1, A M Porrini, A Giampietro

  • 1Department of Clinical Neurology, University of Chieti, Italy.

Acta Neurologica
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance.

European review for medical and pharmacological sciences·2023
Same author

Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY.

Journal of endocrinological investigation·2022
Same author

Synchronous bilateral adrenalectomy in ACTH-dependent hypercortisolism: predictors, biomarkers and outcomes.

Endocrine·2019
Same author

Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.

Pituitary·2019
Same author

Understanding the effect of acromegaly on the human skeleton.

Expert review of endocrinology & metabolism·2018
Same author

Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).

Journal of endocrinological investigation·2018
Same journal

Biological research in epileptics: accumulation of ossiaromatic substances detected with the xanthoproteic reaction of Becher.

Acta neurologica·2010
Same journal

Biological research in epileptics; convulsive action of phenolic derivatives.

Acta neurologica·2010
Same journal

Natural immunity and endorachid therapy; changes in blood lysozyme in relation to endorachid treatment with triod and nicotinic acid.

Acta neurologica·2010
Same journal

On the weight value of the liver in prococeous dementia and in love.

Acta neurologica·2010
Same journal

Human and experimental reflex epilepsy.

Acta neurologica·2010
Same journal

Pharmacological research on bulbocapnine, the trend of calcium and potassium on the dog's blood serum during prolonged treatment with bulbocapnine.

Acta neurologica·2010
See all related articles

Multiple sclerosis (MS) patients show immune system imbalances, with increased CD4+CD29+ cells and decreased CD21+ cells. This study reveals altered T and B cell subpopulations in MS, impacting immune regulation.

Area of Science:

  • Immunology
  • Neuroscience
  • Hematology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Understanding T and B cell subpopulation dynamics is crucial for MS pathogenesis.
  • Previous research suggests immune dysregulation in MS, but specific T and B cell interactions require further elucidation.

Purpose of the Study:

  • To investigate the relationships between T and B cell subpopulations in untreated multiple sclerosis (MS) patients.
  • To identify potential immune system imbalances in MS by analyzing lymphocyte profiles.
  • To correlate specific cell subpopulation changes with MS disease activity and progression.

Main Methods:

  • Two-color flow-cytometry was employed to analyze peripheral blood lymphocytes.

Related Experiment Videos

  • Peripheral blood samples were collected from 46 untreated MS patients, 36 other medical disease (OMD) patients, and 19 healthy control (HC) subjects.
  • Analysis focused on key T and B cell markers, including CD4, CD29, CD21, CD25, and CD45RA.

    • Main Results:

    • MS patients exhibited an increased total lymphocyte count compared to controls.
    • A significant increase in CD4+CD29+ cells (T helper cells) was observed in MS patients.
    • A decrease in CD21+ cells (B cell marker) was noted, potentially indicating B cell activation.
    • Elevated CD25+ cells (T cell activation marker) were found in relapsing-remitting MS patients.
    • Progressive MS patients showed a decrease in CD4+CD45RA+ cells (suppressor inducer T cells).

    Conclusions:

    • The study demonstrates an imbalanced immune system in MS patients, characterized by altered T and B cell subset levels.
    • Increased CD4+CD29+ and decreased CD21+ cells suggest a dysregulated immune response potentially linked to antibody production.
    • Changes in CD25+ and CD4+CD45RA+ cells highlight distinct immune profiles in different MS disease courses (relapsing-remitting vs. progressive).
    • These findings contribute to understanding the complex immunological landscape of multiple sclerosis.